Publications by authors named "Misty Shields"

Claim this Profile
M
Management of Central Nervous System Progression With Dose-Escalated Lorlatinib in ALK-Positive NSCLC: A Report of 2 Cases and Literature Review.
Noah H Richardson, Alexander S Watson, Tejas Patil, David Ross Camidge, Nasser H Hanna, Misty D Shields

Clin Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of Rare Lung Tumors: Adenosquamous Carcinoma and Pulmonary Carcinosarcoma.
Tianhao Zhou, Olivia C Terry, Katherine G Minton, Lisa Poole, Stephen V Liu, Misty D Shields

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity.
Avisek Banerjee, Ioannis Vathiotis, Debdatta Halder, Utsav Sen, Xuejun Wang, Misty D Shields

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024.
Narjust Florez, Sandip Patel, Heather A Wakelee, Julia Rotow, Elaine Shum, Misty Shields

Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tarlatamab-Induced Tumor Lysis Syndrome in Small Cell Carcinoma: Case Series.
Brook M Lobsiger, Ashley S Huh-Brown, Jacob S Edmisson, Brock O'Keefe, Jinesh Gheeya, Misty D Shields

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer.
Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser H Hanna, Sandra Althouse

Int J Radiat Oncol Biol Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances of the year: Small cell lung cancer.
Misty D Shields, Anne C Chiang, Lauren A Byers

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-173: Impact of Social Determinants of Health on Lung Cancer Screening and Small Cell Lung Cancer Outcomes in a County Hospital.
Ahmad Karkash, Weston He, Mya Tran, Julian A Marin-Acevedo, Misty Dawn Shields

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-059: Exploring Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Squamous Cell Carcinoma (LSCC) in North America.
Justin W Shi, Ahmad Karkash, Weston He, Mya Tran, Misty Dawn Shields

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BPI25-018: Impact of Early Palliative Care on Outcomes in Small Cell Lung Cancer.
Ahmad Karkash, Weston He, Mya Tran, Julian A Marin-Acevedo, Misty Dawn Shields

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-074: Outcomes to Immune Checkpoint Inhibitors (ICIs) According to Programmed Death-Ligand 1 (PD-L1) Levels in KRAS-, KEAP1-, STK11-Mutant Lung Squamous Cell Carcinoma (LSCC).
Justin W Shi, Ahmad Karkash, Weston He, Mya T Tran, Yan Han, Misty Dawn Shields

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer.
Subhamoy Chakraborty, Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Misty D Shields

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors.
Misty D Shields, Katherine G Minton, Mya Tran, Peter R Gunderman, Lisbeth G Larsson

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer.
Subhamoy Chakraborty, Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Misty D Shields

Cell Rep Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining neoadjuvant immunotherapy for resectable lung cancer.
Misty D Shields, Christine M Lovly

Nat Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenocarcinoma Harboring Fusion Treated With Osimertinib: A Case Report.
Sunny Y Lai, Noah H Richardson, Mya Tran, Nasser H Hanna, Misty D Shields

JTO Clin Res Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.
Brian Schlick, Misty Dawn Shields, Julian A Marin-Acevedo, Ishika Patel, Bruna Pellini

Curr Treat Options Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
Misty Dawn Shields, Kevin Chen, Giselle Dutcher, Ishika Patel, Bruna Pellini

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.
Kevin Chen, Misty D Shields, Pradeep S Chauhan, Ricardo J Ramirez, Peter K Harris

Mol Diagn Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.
Misty Dawn Shields, William Paul Skelton, Damian A Laber, Michael Verbosky, Noman Ashraf

J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.
Misty D Shields, J Kevin Hicks, Theresa A Boyle, Eric B Haura, Benjamin C Creelan

J Thorac Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.
Misty Dawn Shields, Julian A Marin-Acevedo, Bruna Pellini

Am Soc Clin Oncol Educ Book· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of selected toxicity endpoints of alpelisib.
Misty Shields, Qianxing Mo, Melissa Armitage, Susan C Sharpe, Ricardo L B Costa

Oncotarget· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.
Pei-Hsuan Chen, Ling Cai, Kenneth Huffman, Chendong Yang, Jiyeon Kim, Misty D Shields

Mol Cell· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.
Jihan K Osborne, Jill E Larsen, Misty D Shields, Joshua X Gonzales, David S Shames

Proc Natl Acad Sci U S A· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis